StockData
GRAIL, Inc. logo

GRAIL, Inc. (GRAL) income statement

GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$102.10−3.78 (-3.57%)

Close on Nov 18, 2026Market cap $4.56BP/E –Yield –

GRAIL, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-338.4%
Net margin
-236.9%
Return on equity, FY2025
-16.1%

Financial strength

Current ratio
10.95
Debt to equity
–
Debt to assets
–
Cash to current liabilities
66.6%

Valuation

P/E ratio
–
Price to sales
27.59
Price to book
1.79
Dividend yield
–

See a number that looks wrong?